We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLTA
2901
DELISTED
Volta Inc.
VLTA
$7K ﹤0.01%
20,158
-28,300
-58% -$21.5K
PRTY
2902
DELISTED
Party City Holdco Inc.
PRTY
$7K ﹤0.01%
18,082
-41,700
-70% -$41.9K
BOAC.WS
2903
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$7K ﹤0.01%
46,500
CRBP icon
2904
Corbus Pharmaceuticals
CRBP
$192M
$6K ﹤0.01%
1,877
IBIO icon
2905
iBio
IBIO
$71M
$6K ﹤0.01%
645
WGSWW
2906
DELISTED
GeneDx Holdings Warrant
WGSWW
$5K ﹤0.01%
280,194
-15,849
-5% -$1.64K
AHRNW
2907
DELISTED
Ahren Acquisition Corp Warrants
AHRNW
$5K ﹤0.01%
+55,000
New +$5K
AUD
2908
DELISTED
Audacy, Inc.
AUD
$5K ﹤0.01%
20,319
+8,213
+68% +$2.59K
STAB
2909
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$5K ﹤0.01%
61,200
SNCE
2910
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4K ﹤0.01%
+509
New +$9.96K
UTAAW
2911
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$4K ﹤0.01%
+36,750
New +$5.42K
SVNAW
2912
DELISTED
7 Acquisition Corp Warrant
SVNAW
$4K ﹤0.01%
+38,025
New +$3.46K
ATIP
2913
DELISTED
ATI Physical Therapy, Inc.
ATIP
$4K ﹤0.01%
282
VTGN icon
2914
VistaGen Therapeutics
VTGN
$11.7M
$3K ﹤0.01%
1,132
+534
+89% +$2.01K
MTEM
2915
DELISTED
Molecular Templates, Inc.
MTEM
$3K ﹤0.01%
667
BRD.WS
2916
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$3K ﹤0.01%
+56,400
New +$3.63K
CMCAW
2917
DELISTED
Capitalworks Emerging Markets Acquisition Corp Warrant
CMCAW
$2K ﹤0.01%
+55,375
New +$2.4K
NETC.WS
2918
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$2K ﹤0.01%
+38,375
New +$2.29K
GEEXW
2919
DELISTED
Games & Esports Experience Acquisition Corp. Warrants
GEEXW
$2K ﹤0.01%
+55,090
New +$2.32K
RKLY
2920
DELISTED
Rockley Photonics Holdings Limited
RKLY
$2K ﹤0.01%
14,094
ONYXW
2921
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1K ﹤0.01%
37,750
PRPC.WS
2922
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$1K ﹤0.01%
12,125
BPACW
2923
DELISTED
Bullpen Parlay Acquisition Company Warrant
BPACW
$1K ﹤0.01%
+55,000
New +$2.65K
EUCRW
2924
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$1K ﹤0.01%
22,697
MLAIW
2925
DELISTED
McLaren Technology Acquisition Corp. Warrant
MLAIW
$1K ﹤0.01%
37,750

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.